Bacil Pharma (BACPHAR) Shareholding Pattern

NSE: BACPHAR • Promoter, FII, DII Holdings for Tickjournal
Promoter Holding 0.08%
FII Holding 0.00%
DII Holding 0.00%
Public Holding 80.95%
Total Shareholders 7,431
As of Sept 2025
View the latest shareholding pattern of Bacil Pharma (BACPHAR) including promoter, FII, DII, and public holdings. Track BACPHAR ownership changes over time and document your investment thesis in Tickjournal — your personal trade journal. (See Bacil Pharma yearly highs lows)

Bacil Pharma (BACPHAR) Shareholding Summary

  • Promoter holding remains unchanged at 0.08% in Sept 2025
  • FII/FPI holding remains unchanged at 0.00% in Sept 2025
  • DII holding remains unchanged at 0.00% in Sept 2025
  • Public holding has increased from 79.74% to 80.95% in Sept 2025
  • Number of shareholders decreased from 7,541 to 7,431 in Sept 2025

BACPHAR Quarterly Ownership Changes

Quarter-over-quarter changes for Bacil Pharma from Jul 2025 to Sept 2025.

Promoter Holding Change
Jul 2025 to Sept 2025
No Change
FII Holding Change
Jul 2025 to Sept 2025
No Change
DII Holding Change
Jul 2025 to Sept 2025
No Change
Public Holding Change
Jul 2025 to Sept 2025
+1.21%

Bacil Pharma (BACPHAR) Quarterly Shareholding Trends

Visual breakdown of BACPHAR ownership distribution over time. Learn more about BACPHAR dividend track record.

Promoter
FII
DII
Public
Government

Rising institutional holdings in BACPHAR often correlate with improved fundamentals. Check out BACPHAR P/E ratio.

Bacil Pharma (BACPHAR) Shareholding Data

Download complete BACPHAR ownership data for offline analysis. Discover BACPHAR complete financial.

Period Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Sept 2025 0.08% 0.00% 0.00% 0.00% 80.95% 18.97% 100.00% 7,431
Jul 2025 0.08% 0.00% 0.00% 0.00% 79.74% 20.18% 100.00% 7,541
Jun 2025 0.20% 0.00% 0.00% 0.00% 77.37% 22.43% 100.00% 7,532
Mar 2025 0.20% 0.00% 0.00% 0.00% 75.77% 24.03% 100.00% 7,638
Dec 2024 10.60% 0.00% 0.00% 0.00% 67.42% 21.98% 100.00% 7,461
Sept 2024 20.70% 0.00% 0.00% 0.00% 59.61% 19.69% 100.00% 6,902
Jun 2024 42.67% 0.00% 0.00% 0.00% 53.91% 3.42% 100.00% 6,794
Mar 2024 42.67% 0.00% 0.00% 0.00% 53.89% 3.44% 100.00% 6,770
Dec 2023 42.67% 0.00% 0.00% 0.00% 53.77% 3.56% 100.00% 6,628
Sept 2023 42.67% 0.00% 0.00% 0.00% 53.80% 3.53% 100.00% 6,647
Jun 2023 42.67% 0.00% 0.00% 0.00% 53.79% 3.54% 100.00% 6,663
Mar 2023 42.67% 0.00% 0.00% 0.00% 53.76% 3.57% 100.00% 6,649
Dec 2022 42.67% 0.00% 0.00% 0.00% 53.77% 3.56% 100.00% 6,548
Sept 2022 42.67% 0.00% 0.00% 0.00% 53.74% 3.59% 100.00% 6,545
Jun 2022 42.67% 0.00% 0.00% 0.00% 52.90% 4.43% 100.00% 6,532
Mar 2022 42.67% 0.00% 0.00% 0.00% 52.83% 4.50% 100.00% 6,514
Dec 2021 42.67% 0.00% 0.00% 0.00% 52.88% 4.45% 100.00% 6,461
Sept 2021 42.67% 0.00% 0.00% 0.00% 53.88% 3.45% 100.00% 6,319
Jun 2021 42.67% 0.00% 0.00% 0.00% 53.85% 3.48% 100.00% 6,410
Mar 2021 42.67% 0.00% 0.00% 0.00% 51.38% 5.95% 100.00% 0

BACPHAR promoter holding above 50% indicates strong insider confidence. Explore the BACPHAR share price data for detailed insights.

Quarter Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Sept 2025 0.08% 0.00% 0.00% 0.00% 80.95% 18.97% 100.00% 7,431
Jul 2025 0.08% 0.00% 0.00% 0.00% 79.74% 20.18% 100.00% 7,541
Jun 2025 0.20% 0.00% 0.00% 0.00% 77.37% 22.43% 100.00% 7,532
Mar 2025 0.20% 0.00% 0.00% 0.00% 75.77% 24.03% 100.00% 7,638
Dec 2024 10.60% 0.00% 0.00% 0.00% 67.42% 21.98% 100.00% 7,461
Sept 2024 20.70% 0.00% 0.00% 0.00% 59.61% 19.69% 100.00% 6,902
Jun 2024 42.67% 0.00% 0.00% 0.00% 53.91% 3.42% 100.00% 6,794
Mar 2024 42.67% 0.00% 0.00% 0.00% 53.89% 3.44% 100.00% 6,770
Dec 2023 42.67% 0.00% 0.00% 0.00% 53.77% 3.56% 100.00% 6,628
Sept 2023 42.67% 0.00% 0.00% 0.00% 53.80% 3.53% 100.00% 6,647
Jun 2023 42.67% 0.00% 0.00% 0.00% 53.79% 3.54% 100.00% 6,663
Mar 2023 42.67% 0.00% 0.00% 0.00% 53.76% 3.57% 100.00% 6,649

Quarterly data helps track institutional investment cycles.

Year Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Mar 2025 0.20% 0.00% 0.00% 0.00% 75.77% 24.03% 100.00% 7,638
Dec 2024 10.60% 0.00% 0.00% 0.00% 67.42% 21.98% 100.00% 7,461
Dec 2023 42.67% 0.00% 0.00% 0.00% 53.77% 3.56% 100.00% 6,628
Dec 2022 42.67% 0.00% 0.00% 0.00% 53.77% 3.56% 100.00% 6,548
Dec 2021 42.67% 0.00% 0.00% 0.00% 52.88% 4.45% 100.00% 6,461

Year-over-year trends reveal long-term ownership shifts.

Understanding Bacil Pharma (BACPHAR) Shareholding Pattern

Bacil Pharma shareholding pattern reveals who owns BACPHAR stock and how ownership changes over time. High promoter stakes in BACPHAR often signal management confidence, while rising FII/DII holdings suggest growing institutional interest. Use Tickjournal to log these insights alongside your BACPHAR trades. BACPHAR book value comparison

Combine BACPHAR ownership analysis with price movements and financial performance for a complete investment picture. (See BACPHAR enterprise value)